Back to Journals » Drug Design, Development and Therapy » Volume 12

Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway

Total article views   HTML views PDF downloads Totals
9,729 Dovepress* 9,326+ 745 10,071
PubMed Central* 403 142 545
Totals 9,729 887 10,616
*Since 22 November 2018

View citations on PubMed Central and Google Scholar